Skip to main content
Log in

Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C

  • Symposium
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Haimovich J, David HM, Schreiber AB (1990) Human antimouse immunoglobulins in sera of patients treated chronically with monoclonal antibody purified Factor VIII. Semin Hematol 27 [Suppl 2]: 11–15

    Google Scholar 

  2. Kasper CK (1984) Measurement of Factor VIII inhibitors. Progr Clin Biol Res 150: 87–98

    Google Scholar 

  3. Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner M, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, van Eys J (1975) A more uniform measurement of Factor VIII inhibitors. Thromb Diath Haemorrh 34: 875–876

    Google Scholar 

  4. Lusher JM, Salzman PM, Monoclate Study Group (1990) Viral safety and inhibitor development associated with Factor VIII C ultra-purified from plasma in hemophiliacs previously unexposed to Factor VIII C concentrates. Semin Hematol 27 [Suppl 2]: 1–7

    Google Scholar 

  5. Mannucci PM, Colombo M (1988) Virucidal treatment of clotting factor concentrates. Lancet II: 782–785

    Google Scholar 

  6. Mannucci PM, Colombo M (1989) Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis. Thromb Haemost 61: 532–534

    Google Scholar 

  7. Mannucci PM, Schimpf K, Brettler D, Colombo M, Lechner K, Lusher JM, Roberts H (1991) Hepatitis C virus is not transmitted by a high purity, pasteurized Factor VIII concentrate. Ann Intern Med 113: 27–32

    Google Scholar 

  8. Schimpf K, Mannucci POM, Kreutz W, Brackmann HH, Auerswald G, Ciavarella N, Mösseler J, De Rosa V, Kraus B, Brueckmann C, Mancuso G, Mittler U, Haschke F, Morfini M (1987) Absence of hepatitis after treatment with a pasteurized F VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 316: 918–922

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

It should be noted that not all of the tests listed relate to hepatitis; additional surveillance for other possible complications of treatment are included as well

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lusher, J.M. Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C. Ann Hematol 63, 138–141 (1991). https://doi.org/10.1007/BF01703244

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01703244

Keywords

Navigation